ADC Biotech Ona Therapeutics Secures $86.6M in Series B Raise

Ona Therapeutics bags $86.6m Series B for stealth ADC push - European Biotechnology Magazine

Barcelona-based Ona Therapeutics has raised US$86.6m in a Series B financing to advance a new generation of antibody-drug conjugates into clinical development. The post Ona Therapeutics bags $86.6m Series B for stealth ADC push appeared first on European Biotechnology Magazine.

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Proceeds to support clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancer Financing supports Ona’s transition […]

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic. CEO Valerie Vanhooren told Endpoints News in an interview that the cash should provide two-and-a-half ...